Related references
Note: Only part of the references are listed.The Hepatic Microenvironment Uniquely Protects Leukemia Cells through Induction of Growth and Survival Pathways Mediated by LIPG
Haobin Ye et al.
CANCER DISCOVERY (2021)
Tea polyphenol modified, photothermal responsive and ROS generative black phosphorus quantum dots as nanoplatforms for promoting MRSA infected wounds healing in diabetic rats
Shibo Xu et al.
JOURNAL OF NANOBIOTECHNOLOGY (2021)
(-)-Epigallocatechin-3-gallate induces apoptosis and differentiation in leukaemia by targeting reactive oxygen species and PIN1
Fernanda Isabel Della Via et al.
SCIENTIFIC REPORTS (2021)
Bone-Targeting Polymer Vesicles for Effective Therapy of Osteoporosis
Xue Zhou et al.
NANO LETTERS (2021)
A two-pronged anti-leukemic agent based on a hyaluronic acid-green tea catechin conjugate for inducing targeted cell death and terminal differentiation
Kun Liang et al.
BIOMATERIALS SCIENCE (2020)
Metabolic dependencies and vulnerabilities in leukemia
Marissa Rashkovan et al.
GENES & DEVELOPMENT (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Targeting FLT3 mutations in AML: review of current knowledge and evidence
Naval Daver et al.
LEUKEMIA (2019)
Green tea polyphenol EGCG causes anti-cancerous epigenetic modulations in acute promyelocytic leukemia cells
Veronika Borutinskaite et al.
LEUKEMIA & LYMPHOMA (2018)
Epigallocatechin-3-gallate enhances differentiation of acute promyelocytic leukemia cells via inhibition of PML-RAR and HDAC1
Maliheh Moradzadeh et al.
PHYTOTHERAPY RESEARCH (2018)
Highly Augmented Drug Loading and Stability of Micellar Nanocomplexes Composed of Doxorubicin and Poly(ethylene glycol)-Green Tea Catechin Conjugate for Cancer Therapy
Kun Liang et al.
ADVANCED MATERIALS (2018)
Targeted drug delivery for tumor therapy inside the bone marrow
Chao-Feng Mu et al.
BIOMATERIALS (2018)
Foe to Friend: Supramolecular Nanomedicines Consisting of Natural Polyphenols and Bortezomib
Changping Wang et al.
NANO LETTERS (2018)
Insight into Cellular Uptake and Intracellular Trafficking of Nanoparticles
Parisa Foroozandeh et al.
NANOSCALE RESEARCH LETTERS (2018)
mTOR signalling and cellular metabolism are mutual determinants in cancer
Dirk Mossmann et al.
NATURE REVIEWS CANCER (2018)
A new insight in chimeric antigen receptor-engineered T cells for cancer immunotherapy
Erhao Zhang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
FLT3 Inhibitors in Acute Myeloid Leukemia: Current Status and Future Directions
Maria Larrosa-Garcia et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Hyaluronic acid-green tea catechin micellar nanocomplexes: Fail-safe cisplatin nanomedicine for the treatment of ovarian cancer without off-target toxicity
Ki Hyun Bae et al.
BIOMATERIALS (2017)
Acute myeloid leukaemia genomics
Michael Medinger et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
In vivo targeting of leukemia stem cells by directing parthenolide-loaded nanoparticles to the bone marrow niche
H. Zong et al.
LEUKEMIA (2016)
Inhibition of bone loss with surface-modulated, drug-loaded nanoparticles in an intraosseous model of prostate cancer
Isaac M. Adjei et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Passive and semi-active targeting of bone marrow and leukemia cells using anionic low cholesterol liposomes
Paul Tardi et al.
JOURNAL OF DRUG TARGETING (2016)
Green tea polyphenol epigallocatechin-3-gallate, differentially induces apoptosis in CLL B-and T-Cells but not in healthy B-and T-Cells in a dose dependant manner
Scott Cornwall et al.
LEUKEMIA RESEARCH (2016)
Aberrant activation of the PI3K/mTOR pathway promotes resistance to sorafenib in AML
O. Lindblad et al.
ONCOGENE (2016)
Priming the Surface of Orthopedic Implants for Osteoblast Attachment in Bone Tissue Engineering
Kiat Hwa Chan et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2015)
Metformin synergistically sensitizes FLT3-ITD-positive acute myeloid leukemia to sorafenib by promoting mTOR-mediated apoptosis and autophagy
Fangfang Wang et al.
LEUKEMIA RESEARCH (2015)
Galactosylated polymeric carriers for liver targeting of sorafenib
Emanuela F. Craparo et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2014)
Self-assembled micellar nanocomplexes comprising green tea catechin derivatives and protein drugs for cancer therapy
Joo Eun Chung et al.
NATURE NANOTECHNOLOGY (2014)
The variety of leukemic stem cells in myeloid malignancy
D. H. Wiseman et al.
ONCOGENE (2014)
Engineered nanomedicine for myeloma and bone microenvironment targeting
Archana Swami et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Engineered nanoparticles interacting with cells: size matters
Li Shang et al.
JOURNAL OF NANOBIOTECHNOLOGY (2014)
Hyaluronic acid based self-assembling nanosystems for CD44 target mediated siRNA delivery to solid tumors
Shanthi Ganesh et al.
BIOMATERIALS (2013)
Phosphodiesterase 5 inhibitor acts as a potent agent sensitizing acute myeloid leukemia cells to 67-kDa laminin receptor-dependent apoptosis
Motofumi Kumazoe et al.
FEBS LETTERS (2013)
Sorafenib Inhibits Lymphoma Xenografts by Targeting MAPK/ERK and AKT Pathways in Tumor and Vascular Cells
Carmelo Carlo-Stella et al.
PLOS ONE (2013)
Leucyl-tRNA Synthetase Is an Intracellular Leucine Sensor for the mTORC1-Signaling Pathway
Jung Min Han et al.
CELL (2012)
Survival for older patients with acute myeloid leukemia: a population-based study
Betul Oran et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
A delivery system targeting bone formation surfaces to facilitate RNAi-based anabolic therapy
Ge Zhang et al.
NATURE MEDICINE (2012)
Inhibition of Stabilin-2 elevates circulating hyaluronic acid levels and prevents tumor metastasis
Yoshikazu Hirose et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
E-Selectin-Targeted Porous Silicon Particle for Nanoparticle Delivery to the Bone Marrow
Aman P. Mann et al.
ADVANCED MATERIALS (2011)
Stromal Niche Cells Protect Early Leukemic FLT3-ITD+ Progenitor Cells against First-Generation FLT3 Tyrosine Kinase Inhibitors
Amanda Parmar et al.
CANCER RESEARCH (2011)
Cytotoxicity of arsenic trioxide is enhanced by (-)-epigallocatechin-3-gallate via suppression of ferritin in cancer cells
Te-Chang Lee et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2011)
Epigallocatechin-3-gallate induces cell death in acute myeloid leukaemia cells and supports all-trans retinoic acid-induced neutrophil differentiation via death-associated protein kinase 2
Adrian Britschgi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Quantitation of sorafenib and its active metabolite sorafenib N-oxide in human plasma by liquid chromatography-tandem mass spectrometry
Lie Li et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2010)
Stabilins are expressed in bone marrow sinusoidal endothelial cells and mediate scavenging and cell adhesive functions
Hong Qian et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Contribution of bone microenvironment to leukemogenesis and leukemia progression
F. Ayala et al.
LEUKEMIA (2009)
Cancer prevention by tea: animal studies, molecular mechanisms and human relevance
Chung S. Yang et al.
NATURE REVIEWS CANCER (2009)
Preclinical versus clinical drug combination studies
Ting-Chao Chou
LEUKEMIA & LYMPHOMA (2008)
Aminoacyl tRNA synthetases and their connections to disease
Sang Gyu Park et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The colloid structural forces as a tool for particle characterization and control of dispersion stability
Elka S. Basheva et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2007)
Endocytic function, glycosaminoglycan specificity, and antibody sensitivity of the recombinant human 190-kDa hyaluronan receptor for endocytosis (HARE)
EN Harris et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Expression of stabilin-2, a novel fasciclin-like hyaluronan receptor protein, in murine sinusoidal endothelia, avascular tissues, and at solid/liquid interfaces
M Falkowski et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2003)
Treatment of acute promyelocytic leukemia with ATRA and AS2O3 -: A model of molecular target-based cancer therapy
J Fang et al.
CANCER BIOLOGY & THERAPY (2002)
Share Paper
